APA (7th ed.) Citation

Smolinska, A. A., Swoboda, J., Fendler, W., Lerch, M. M., Sendler, M., & Moskwa, P. (2018). MiR-502 is the first reported miRNA targeting simultaneously classical non-homologous end joining (NHEJ) and the cell cycle response. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 18(4), S119. https://doi.org/10.1016/j.pan.2018.05.321

Chicago Style (17th ed.) Citation

Smolinska, Agnieszka Anna, Julia Swoboda, Wojciech Fendler, Markus M. Lerch, Matthias Sendler, and Patryk Moskwa. "MiR-502 Is the First Reported MiRNA Targeting Simultaneously Classical Non-homologous End Joining (NHEJ) and the Cell Cycle Response." Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.] 18, no. 4 (2018): S119. https://doi.org/10.1016/j.pan.2018.05.321.

MLA (9th ed.) Citation

Smolinska, Agnieszka Anna, et al. "MiR-502 Is the First Reported MiRNA Targeting Simultaneously Classical Non-homologous End Joining (NHEJ) and the Cell Cycle Response." Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.], vol. 18, no. 4, 2018, p. S119, https://doi.org/10.1016/j.pan.2018.05.321.